James Armitage - 15 Jun 2023 Form 4 Insider Report for Cardiff Oncology, Inc. (CRDF)

Role
Director
Signature
/s/ James Armitage
Issuer symbol
CRDF
Transactions as of
15 Jun 2023
Transactions value $
$0
Form type
4
Filing time
20 Jun 2023, 17:06:48 UTC
Previous filing
11 Oct 2022
Next filing
01 Jul 2024
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction CRDF Stock Options Award $0 +27.7K +30.92% $0.00 117K 15 Jun 2023 Common Stock 27.7K $1.59 Direct
* An asterisk sign (*) next to the price indicates that the price is likely invalid.